Fenofibrate Capsules, USP 200 mg
Ajanta Pharma is recalling Fenofibrate Capsules, USP 200 mg, due to manufacturing process deviations.
Contact your healthcare provider or pharmacist if you have concerns about your medication. Do not stop taking prescribed medication without consulting a medical professional.
Recall at a glance
- Quantity recalled
- 3648 bottles
Why it was recalled
Ajanta Pharma is recalling Fenofibrate Capsules, USP 200 mg, due to current good manufacturing practice (CGMP) deviations. The affected product is packaged in 100-count bottles.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Fenofibrate Capsules, USP
- Lot code
- PA02216
- Strength
- 200 mg
- NDC / UPC
- NDC 27241-120-04
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other Manufacturing Deviation recalls
Other recent recalls from Ajanta Pharma USA Inc
Editorial summary by Recall Canary · summary updated 2026-06-23 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification